ARTICLE | Company News
Management tracks
December 15, 2016 1:34 AM UTC
The Cancer Research Society (Montreal, Quebec) named Max Fehlmann president and CEO, effective Jan. 16. He was CEO at the Neomed Institute (Montreal, Quebec).
Cancer company Harpoon Therapeutics Inc. (Cambridge, Mass.) hired Gerald McMahon as president and CEO. He succeeds interim CEO and co-founder Patrick Baeuerle, who will remain a director. McMahon was president and CEO at Kolltan Pharmaceuticals Inc., which Celldex Therapeutics Inc. (NASDAQ:CLDX) acquired...